An impurity of Felypressin. Felypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As. It physiologically effects on vascular SMC's due to the form in which it is administered. Its receptors are found in various sites around the body. The major points include the CNS, Liver, Anterior Pituitary, Muscle (both vascular and non-vascular smooth muscle), and Platelets (CLAMP).
CAT No: 10-101-190
Felypressin Impurity C is a peptide-related compound that arises as a structurally defined byproduct during the synthesis or degradation of felypressin, a nonapeptide vasoconstrictor analog. As a distinct molecular entity, this impurity possesses unique sequence or conformational characteristics that set it apart from the parent peptide, making it highly relevant for advanced analytical, quality control, and structure-activity relationship (SAR) studies. Its presence and behavior provide crucial insights into peptide synthesis fidelity, process optimization, and the overall integrity of peptide-based research materials. Understanding and characterizing such impurities is essential for researchers working in the field of peptide chemistry, where precision and reproducibility are paramount.
Analytical method development: Felypressin Impurity C serves as a valuable reference standard in the development and validation of analytical techniques such as high-performance liquid chromatography (HPLC), mass spectrometry, and capillary electrophoresis. By incorporating this impurity into method design, analysts can assess the specificity, sensitivity, and resolution of their assays when distinguishing between target peptides and structurally related byproducts. The availability of well-characterized impurities enables more robust quantification, accurate impurity profiling, and the establishment of reliable detection limits, thereby supporting rigorous quality assurance protocols in peptide research and manufacturing environments.
Peptide synthesis optimization: The identification and study of Felypressin Impurity C provide critical feedback for improving synthetic routes and purification strategies in peptide manufacturing. Tracking the formation and prevalence of this impurity during various stages of solid-phase or solution-phase peptide synthesis allows chemists to pinpoint reaction conditions that favor or suppress its generation. Such insights inform the selection of reagents, coupling strategies, and purification methods, ultimately enhancing the yield and homogeneity of the desired peptide product while minimizing unwanted byproducts.
Structural elucidation and SAR studies: Felypressin Impurity C offers a unique opportunity for structural elucidation and comparative structure-activity relationship investigations. By analyzing its sequence, conformation, and physicochemical properties relative to the parent peptide, researchers can better understand the impact of minor sequence variations on biological or physicochemical behavior. These studies are instrumental in mapping the tolerance of peptide scaffolds to modifications, informing the rational design of analogs with tailored properties, and elucidating the mechanisms underlying peptide function or instability.
Reference material for impurity profiling: In regulated and research peptide production settings, the accurate identification and quantification of minor impurities are essential for ensuring product consistency and integrity. Felypressin Impurity C, when available as a characterized reference compound, supports the establishment of impurity profiles for peptide batches. Its use enables laboratories to benchmark analytical performance, monitor lot-to-lot variability, and document the presence of trace byproducts with high confidence, all of which are critical for maintaining the reliability of peptide-based experimental systems.
Stability and degradation studies: The presence and behavior of Felypressin Impurity C under various storage, processing, and formulation conditions provide valuable information about the stability and degradation pathways of peptide products. By subjecting both the parent peptide and its impurity to controlled stress conditions—such as temperature fluctuations, pH changes, or exposure to light—researchers can delineate the mechanisms leading to impurity formation. These findings inform best practices for peptide handling and storage, helping to preserve sample integrity and reproducibility in sensitive research applications.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More